Upgrades/Downgrades
Updated: 20-Oct-26 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Myriad Genetics | MYGN | Piper Sandler | Underweight » Neutral | $5 | |
| Venture Global | VG | Wells Fargo | Equal Weight » Overweight | $21 | |
| Trex | TREX | Stifel | Hold » Buy | $55 | |
| TKO Group Holdings | TKO | Arete | Neutral » Buy | $208 | |
| Healthcare Realty | HR | Deutsche Bank | Hold » Buy | $23 | |
| BlackRock | BLK | TD Cowen | Hold » Buy | $1405 | |
| Arhaus | ARHS | Piper Sandler | Neutral » Overweight | $13 | |
| American Electric | AEP | BTIG Research | Neutral » Buy | $147 | |
| Akamai Tech | AKAM | Raymond James | Outperform » Strong Buy | $170 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Live Nation | LYV | CFRA | Hold » Sell | ||
| Zoetis | ZTS | Jefferies | Buy » Hold | $83 | |
| Werner Enterprises | WERN | Robert W. Baird | Outperform » Neutral | $32 | |
| Vodafone PLC | VOD | Barclays | Equal Weight » Underweight | ||
| RELX | RELX | Citigroup | Buy » Neutral | ||
| NuScale Power | SMR | Barclays | Equal Weight » Underweight | $5 | |
| Heartland Express | HTLD | Robert W. Baird | Outperform » Neutral | $12 | |
| EyePoint | EYPT | JP Morgan | Neutral » Underweight | ||
| Essential Properties Realty Trust | EPRT | Deutsche Bank | Buy » Hold | $28 | |
| Elanco Animal Health | ELAN | Jefferies | Buy » Hold | $24 | |
| Apple | AAPL | Loop Capital | Buy » Hold | $330 | |
| EyePoint | EYPT | Mizuho | Outperform » Neutral | $0.50 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Baxter | BAX | Wolfe Research | Peer Perform | ||
| Becton Dickinson | BDX | Wolfe Research | Outperform | ||
| GE HealthCare | GEHC | Wolfe Research | Peer Perform | ||
| Amtech Systems | ASYS | Lake Street | Buy | $22 | |
| Climb Bio | CLYM | Deutsche Bank | Buy | $28 | |
| Tvardi Therapeutics | TVRD | Chardan Capital Markets | Buy | $8 | |
| Thomson Reuters | TRI | Jefferies | Buy | $130 | |
| SiTime | SITM | Rosenblatt | Buy | $750 | |
| nVent Electric | NVT | JP Morgan | Overweight | $167 | |
| News Corp. | NWSA | Raymond James | Outperform | $35 | |
| Modine Manufacturing | MOD | Cantor Fitzgerald | Overweight | $275 | |
| Midera Food Processing | MFP | William Blair | Outperform | ||
| Kestra Medical Technologies | KMTS | Evercore ISI | Outperform | $34 | |
| Ensysce Biosciences | ENSC | Cantor Fitzgerald | Overweight | $2 | |
| Concentra | CON | Stephens | Overweight | $45 | |
| Artivion | AORT | Jefferies | Buy | $31 | |
| ADARx Pharmaceuticals | ADRX | UBS | Buy | $35 | |
| ADARx Pharmaceuticals | ADRX | TD Cowen | Buy | ||
| ADARx Pharmaceuticals | ADRX | Morgan Stanley | Overweight | $32 | |
| ADARx Pharmaceuticals | ADRX | JP Morgan | Overweight | $38 | |
| Kazia Therapeutics | KZIA | Leerink Partners | Outperform | $30 | |
| Restaurant Brands Int'l | QSR | Mizuho | Outperform | $85 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Western Midstream | WES | JP Morgan | Neutral | $50 | |
| Sunoco LP | SUN | JP Morgan | Overweight | $87 | |
| MPLX LP | MPLX | JP Morgan | Neutral | $62 | |
| Hubbell | HUBB | JP Morgan | Neutral | $485 | |
| Zenas Biopharma | ZBIO | Morgan Stanley | Equal-Weight | $32 | |
| Lakefront Biotherapeutics NV | LKFT | Morgan Stanley | Equal-Weight | $26 | |
| Incyte | INCY | Morgan Stanley | Equal-Weight | $119 | |
| Evommune | EVMN | Morgan Stanley | Overweight | $26 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |